The pharmacologic inhibition of protein-serine O-palmitoleoyltransferase porcupine (PORCN), an enzyme necessary for Wnt ligand secretion, synergistically suppressed melanoma progression when combined with anti–CTLA-4 antibody treatment [117]. The gene discussed is PORCN; the disease is melanoma.